Mind Medicine Stock (NASDAQ: MNMD) stock price, news, charts, stock research, profile.
|Vol / Avg.616.000 / 383.495K||Mkt Cap141.935M|
|Day Range- - -||52 Wk Range2.120 - 5.010|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-10-23||RBC Capital||Brian Abrahams||Reiterates||OutperformOutperform||Maintains||-||7.00|
|2023-08-22||Cantor Fitzgerald||Charles Duncan||Reiterates||OverweightOverweight||Maintains||-||7.00|
|2023-08-04||HC Wainwright & Co.||Patrick Trucchio||Reiterates||Buy||Maintains||-||75.00|
|2023-08-04||RBC Capital||Brian Abrahams||Maintains||OutperformOutperform||Raises||5.00||7.00|
You can purchase shares of Mind Medicine (NASDAQ: MNMD) through any online brokerage.
There are no as such competitors for Mind Medicine.
The latest price target for Mind Medicine (NASDAQ: MNMD) was reported by RBC Capital on Monday, October 23, 2023. The analyst firm set a price target for 7.00 expecting MNMD to rise to within 12 months (a possible 97.74% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Mind Medicine (NASDAQ: MNMD) is $3.54 last updated Today at December 7, 2023 at 12:19 PM UTC.
There is no dividend information for Mind Medicine.
Mind Medicine’s Q4 earnings are confirmed for Thursday, March 7, 2024.
There is no upcoming split for Mind Medicine.
Mind Medicine is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.